[English] 日本語
Yorodumi Papers
- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods
Author
Journal
IF

-
Structure paper

TitleStructure of lymphostatin, a large multi-functional virulence factor of pathogenic Escherichia coli.
Journal, issue, pagesNat Commun, Vol. 16, Issue 1, Page 5389, Year 2025
Publish dateJun 25, 2025
AuthorsMatthias Griessmann / Tim Rasmussen / Vanessa J Flegler / Christian Kraft / Ronja Schneider / Max Hateley / Lukas Spantzel / Mark P Stevens / Michael Börsch / Bettina Böttcher /
PubMed AbstractLymphostatin is a key virulence factor of enteropathogenic and enterohaemorrhagic Escherichia coli, playing roles in bacterial colonisation of the gut and in the inhibition of lymphocyte ...Lymphostatin is a key virulence factor of enteropathogenic and enterohaemorrhagic Escherichia coli, playing roles in bacterial colonisation of the gut and in the inhibition of lymphocyte proliferation and proinflammatory responses. The protein's glycosyltransferase and cysteine protease motifs are required for activity against lymphocytes, but high-resolution structural information has proven elusive. Here, we describe the structure of lymphostatin from enteropathogenic E. coli O127:H6, determined by electron cryo-microscopy at different pH values. We observe three conformations of a highly complex molecule with two glycosyltransferase domains, one PaToxP-like protease domain, an ADP-ribosyltransferase domain, a vertex domain and a delivery domain. Long linkers hold these domains together and occlude the catalytic sites of the N-terminal glycosyltransferase and protease domains. Lymphostatin binds to bovine T-lymphocytes and HEK-293T cells, forming clusters at the plasma membrane that are internalized. With six distinct domains, lymphostatin can be regarded as a multitool of pathogenic Escherichia coli, enabling complex interactions with host cells.
External linksNat Commun / PubMed:40562750 / PubMed Central
MethodsEM (single particle)
Resolution2.7 - 4.4 Å
Structure data

EMDB-19982: Lymphostatin, conformation 1, N-terminal part
Method: EM (single particle) / Resolution: 2.7 Å

EMDB-19983: Lymphostatin, conformation 1, local refinement C-terminal part
Method: EM (single particle) / Resolution: 3.0 Å

EMDB-19984: Lymphostatin, conformation 2, N-terminal part
Method: EM (single particle) / Resolution: 2.8 Å

EMDB-19985: Lymphostatin, conformation 2 , local refinement C-terminal part
Method: EM (single particle) / Resolution: 3.8 Å

EMDB-19987, PDB-9euv:
Lymphostatin, conformation 1 (composite structure)
Method: EM (single particle) / Resolution: 3.0 Å

EMDB-19988, PDB-9euw:
Lymphostatin, conformation 2 (composite structure)
Method: EM (single particle) / Resolution: 2.8 Å

EMDB-52985: Lymphostatin Conformation II, Hepes buffer pH8 - consensus map
Method: EM (single particle) / Resolution: 3.3 Å

EMDB-52986: Lymphostatin -Conformation II - Local-Refinement GT-domains
Method: EM (single particle) / Resolution: 3.3 Å

EMDB-52987: Lymphostatin - Conformation II - pH 8, Hepes, focussed on center
Method: EM (single particle) / Resolution: 3.2 Å

EMDB-52988: Lymphostatin - Conformation II - pH8 Hepes, focussed on delivery
Method: EM (single particle) / Resolution: 3.3 Å

EMDB-52989: Lymphostatin - Conformation II - pH 8 Hepes - focussed on C-term
Method: EM (single particle) / Resolution: 4.2 Å

EMDB-52990, PDB-9qb8:
Lymphostatin - Conformation II - pH 8 Hepes
Method: EM (single particle) / Resolution: 3.4 Å

EMDB-52991: Lymphostatin - conformation III - pH 8 focussed on delivery domain
Method: EM (single particle) / Resolution: 4.1 Å

EMDB-52992: Lymphostatin - Conformation III - pH 8 focussed on centre
Method: EM (single particle) / Resolution: 4.2 Å

EMDB-52993: Lymphostatin - Conformation III - pH 8 - focussed on C-term
Method: EM (single particle) / Resolution: 3.6 Å

EMDB-52994: Lymphostatin - conformation III - pH 8 focussed on N-term
Method: EM (single particle) / Resolution: 3.4 Å

EMDB-52995: Lymphostatin - Conformation III - pH 8 - consensus map
Method: EM (single particle) / Resolution: 3.3 Å

EMDB-52996, PDB-9qbb:
Lymphostatin - Conformation III - pH 8
Method: EM (single particle) / Resolution: 3.3 Å

EMDB-53164: Lymphostatin - pH8 phosphate buffer - focussed on C-term
Method: EM (single particle) / Resolution: 4.4 Å

EMDB-53165: Lymphostatin- pH 8.0 phosphate buffer - focussed on delivery domain S1
Method: EM (single particle) / Resolution: 3.1 Å

EMDB-53166: Lymphostatin - pH 8 phosphate buffer - focussed on centre
Method: EM (single particle) / Resolution: 3.1 Å

EMDB-53167: Lymphostatin - pH 8.0 phosphate - focussed on GT-domain
Method: EM (single particle) / Resolution: 3.1 Å

EMDB-53168: Lymphostatin at pH 8 in Phosphate buffer - Consensus Map
Method: EM (single particle) / Resolution: 3.2 Å

EMDB-53169, PDB-9qhh:
Lymphostatin - pH 8 - phosphate buffer
Method: EM (single particle) / Resolution: 3.1 Å

EMDB-53286: Lymphostatin - Conformation I - pH 6.5 phosphate buffer
Method: EM (single particle) / Resolution: 3.5 Å

EMDB-53287: Lymphostatin - conformation II - pH 6.5 phosphate buffer
Method: EM (single particle) / Resolution: 3.4 Å

Chemicals

ChemComp-MN:
Unknown entry

Source
  • escherichia coli o127:h6 str. e2348/69 (bacteria)
  • escherichia coli o127:h6 (bacteria)
  • Escherichia coli O2:H6 (bacteria)
  • Escherichia coli (E. coli)
KeywordsTOXIN / bacterial virulence factor / glycosyltransferase / protease / Virulence Factor Lymphostatin LifA Conformation II / Virulence Factor Lymphostatin LifA Conformation III / Lymphostatin virulence factor A/E bacteria Toxin-like

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

  • Database of articles cited by EMDB, PDB, and SASBDB entries
  • Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi

Read more